Skip to content

China Regenerative Medicine International Ltd Sustainability Reports

The company operates as an investment holding company that develops, manufactures, and sells biomedical products, medical devices, and healthcare services. Its activities mainly focus on regenerative medicine, aesthetic medical services, and tissue engineering solutions.

Sector: Manufacturing

Country: Hong Kong

Exchange: Hong Kong Stock Exchange

FIGI: BBG001SJ8T94

5 reports from 2021 to 2025